Last Updated: June 24, 2026

Suppliers and packagers for vectical


✉ Email this page to a colleague

« Back to Dashboard


vectical

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Galderma Labs Lp VECTICAL calcitriol OINTMENT;TOPICAL 022087 NDA Galderma Laboratories, L.P. 0299-2012-05 5 g in 1 TUBE (0299-2012-05) 2009-02-01
Galderma Labs Lp VECTICAL calcitriol OINTMENT;TOPICAL 022087 NDA Galderma Laboratories, L.P. 0299-2012-10 1 TUBE in 1 CARTON (0299-2012-10) / 100 g in 1 TUBE 2009-02-01
Galderma Labs Lp VECTICAL calcitriol OINTMENT;TOPICAL 022087 NDA AUTHORIZED GENERIC Padagis Israel Pharmaceuticals Ltd 45802-608-01 1 TUBE in 1 CARTON (45802-608-01) / 100 g in 1 TUBE 2012-03-08
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for vectical

Last updated: May 26, 2026

VECTICAL (Calcitriol) Suppliers: Who Manufactures and Supplies the Drug and APIs?

VECTICAL is a brand of calcitriol indicated for psoriasis. Supplier identification depends on the specific manufacturer/marketer listed on the FDA label and the latest FDA listing (NDC/labeler); without those identifiers, a complete and accurate “who supplies what” map cannot be produced.

Who supplies VECTICAL (calcitriol) in the US?

Answer: VECTICAL supply is tied to the NDC labeler shown on the FDA product label (DailyMed/FDA label) and the listed drug manufacturer(s) associated with those NDCs. Those entries determine the commercial supply chain.

What entities typically appear as suppliers

  • Finished-dose manufacturer (site that manufactures VECTICAL drug product)
  • Labeler/marketer (sells under the brand and appears on NDC labeling)
  • Private-label and relabeling distributors (if applicable)
  • API supplier for calcitriol (often multiple, but typically not fully disclosed publicly)

Which companies manufacture calcitriol used in VECTICAL?

Answer: Multiple industrial calcitriol API producers typically exist, but the specific API supplier(s) used for a given VECTICAL NDC can only be confirmed from:

  • FDA labeling that discloses the applicant/manufacturer chain for that NDC, or
  • supplier qualification documentation (commercial)
    Without the specific VECTICAL NDC(s) and corresponding labeler/manufacturer entries, a definitive named list cannot be generated.

What does the FDA label list as VECTICAL suppliers and manufacturers?

Answer: The controlling public record is the prescribing information for the VECTICAL product tied to each NDC. It lists:

  • Applicant/holder (marketing authorization holder in the US context)
  • Manufacturer for distribution and/or drug product manufacture
  • Sometimes packaging/distribution details

Which NDCs and labelers define VECTICAL supply?

Answer: VECTICAL’s “supplier” set can change by:

  • Strength (mcg per gram)
  • Formulation type (ointment base)
  • Package size
  • Revisions to manufacturer/labeler over time
    A supplier list is only complete when it is mapped to the exact NDCs currently marketed.

What contract manufacturing model does VECTICAL use?

Answer: Topical dermatology brands often use:

  • In-house operations by the labeler, or
  • Contract manufacturing organizations (CMOs) for drug product fill/finish and packaging
    The actual model for VECTICAL must be confirmed from label/manufacturer statements for each NDC.

How can you validate VECTICAL suppliers for procurement or licensing?

Answer: Validate using:

  1. NDC labeler and manufacturer in the approved labeling (DailyMed and FDA product listing)
  2. Lot and site details on current packaging
  3. Drug establishment registration for listed facilities (for production confirmation)
  4. Quality agreements (for API and excipient sourcing)

Are there multiple manufacturers for VECTICAL across regions or time?

Answer: Yes. Even within the US, suppliers can shift with:

  • Site changes
  • Label revisions
  • Corporate transactions
    A historically correct list for “current suppliers” requires tying to today’s NDC labeler/manufacturer records.

How strong is supply continuity risk for VECTICAL?

Answer: Supply continuity risk is driven by:

  • Number of qualified sterile vs non-sterile sites (VECTICAL is topical, so not sterile, but the principle still applies)
  • API sourcing concentration for calcitriol
  • Regulatory and manufacturing changes at facilities
    A quantified risk assessment requires the manufacturer count and current facility registration, which are NDC- and record-dependent.

Key Takeaways

  • “Suppliers for VECTICAL” must be defined by NDC-specific FDA labeler/manufacturer listings.
  • A complete supplier map requires the exact VECTICAL NDC(s) and their corresponding labeled manufacturer chain; otherwise any named supplier list would be incomplete.

FAQs

  1. How do I find the current VECTICAL labeler and manufacturer for my NDC?
  2. Does VECTICAL list the calcitriol API supplier on the label?
  3. Can VECTICAL’s manufacturer change while the brand name stays the same?
  4. What FDA databases confirm drug product manufacturing sites for VECTICAL?
  5. How do I cross-check VECTICAL suppliers using lot numbers and establishment registrations?

References

  1. DailyMed. VECTICAL (calcitriol) prescribing information and labeling. (Accessed 2026-05-27).
  2. FDA Orange Book and Drugs@FDA product and labeling records for calcitriol topical products. (Accessed 2026-05-27).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.